Glaucoma start-up gains $16m for implant trial
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,…
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,…